ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1483

High Chronicity Index of the Modified NIH (National Institute of Health) Scoring System of Lupus Nephritis Is Associated with Increased Risk of End-stage Kidney Disease: A Retrospective Single-center Study

Shiori Nakagawa, Yasunori Iwata, Takahiro Yuasa, Keisuke Sako, Keisuke Horikoshi, Taichiro Minami, Megumi Oshima, Tadashi Toyama, Shinji Kitajima, Akinori Hara, Norihiko Sakai, Miho Shimizu and Takashi Wada, Department of Nephrology, Kanazawa University Hospital, Kanazawa, Japan

Meeting: ACR Convergence 2023

Keywords: Lupus nephritis, prognostic factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1442–1487) SLE – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Lupus nephritis (LN) is a major manifestation which develops in more than 50% of patients with systemic lupus erythematosus (SLE), and is also a primary risk factor for morbidity and mortality in these patients. The revision of International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification guidelines for lupus nephritis (LN) was suggested by a working group, who recommended a modified National Institute of Health (NIH) activity and chronicity scoring system to evaluate active and chronic LN lesions. However, whether this approach was useful for estimating long-term prognosis for LN patients is unclear.

Methods: We conducted a retrospective cohort study in Japanese subjects with biopsy-proven LN, between 1977 and 2022. Pathologic lesions were evaluated based on ISN/RPS 2003 classifications and the modified NIH scoring system. Patients were grouped by activity index (low, 0–5; moderate, 6–11; high, 12–24), and chronicity index (low, 0–2; moderate, 3–5; high, 6–12). The primary outcome was a composite of end-stage kidney disease (ESKD) or all-cause death, and the secondary outcome was ESKD alone.

Results: Seventy subjects with a median age of 31 years were included. Median follow-up period was 11.3 years. For the activity index, Kaplan–Meier analysis showed that the survival rate of the primary outcome decreased with a higher activity index (log-rank trend p = 0.026) . Multivariable analysis, adjusted by age and serum creatinine, did not show any significant relationship to the activity index. For the chronicity index, Kaplan–Meier analysis showed that the survival rate of the primary outcome decreased with a higher chronicity index (log-rank trend p< 0.001). Multivariable analysis, adjusted by age and serum creatinine, revealed that moderate (HR 6.18, 95% CI 1.15 to 33.3; p = 0.034) and high chronicity indices (HR 20.33, 95% CI 1.14 to 360.50; p = 0.04) were significant risk factors for the primary outcome. Consistent results with the primary outcome were determined by Kaplan–Meier and univariable analysis.

Conclusion: Moderate and high chronicity indices were associated with an increased ESKD risk for LN. This modified NIH activity and chronicity scoring system may help physicians predict long-term prognosis for patients with LN.


Disclosures: S. Nakagawa: None; Y. Iwata: None; T. Yuasa: None; K. Sako: None; K. Horikoshi: None; T. Minami: None; M. Oshima: None; T. Toyama: None; S. Kitajima: None; A. Hara: None; N. Sakai: None; M. Shimizu: None; T. Wada: None.

To cite this abstract in AMA style:

Nakagawa S, Iwata Y, Yuasa T, Sako K, Horikoshi K, Minami T, Oshima M, Toyama T, Kitajima S, Hara A, Sakai N, Shimizu M, Wada T. High Chronicity Index of the Modified NIH (National Institute of Health) Scoring System of Lupus Nephritis Is Associated with Increased Risk of End-stage Kidney Disease: A Retrospective Single-center Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/high-chronicity-index-of-the-modified-nih-national-institute-of-health-scoring-system-of-lupus-nephritis-is-associated-with-increased-risk-of-end-stage-kidney-disease-a-retrospective-single-center/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-chronicity-index-of-the-modified-nih-national-institute-of-health-scoring-system-of-lupus-nephritis-is-associated-with-increased-risk-of-end-stage-kidney-disease-a-retrospective-single-center/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology